LOU, Z.; WANG, X.; HU, C.; LIU, W.; JI, Y. Combination of anlotinib and second-line chemotherapy as surrogate to reduce immunosuppression in patients with advanced non-small cell lung cancer. Pakistan Journal of Medical Sciences, v. 40, n. 7, 28 Jun. 2024.